Shiyong Xiao

Dr. Shiyong Xiao

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
SXShiyong Xiao
Shiyong Xiao
YDYongqi Dong
Yongqi Dong
YXYuan Xia
Yuan Xia
HXHongyan Xu
Hongyan Xu
FWFalin Weng
Falin Weng
CAChengming Ai
Chengming Ai
Background: In recent years, there has been a growing focus on chronic non-communicable diseases (NCD) and their impact on personal and social health. Effective management of NCD is essential for their prevention and treatment. This study aims to utilize bibliometric methods to analyze and summarize the current development and emerging trends in NCD management. Methods: A literature search and screening were conducted on the Web of Science Core Collection database from January 1, 2004, to December 31, 2023. VOSviewer and Citespace software was performed to examine publication volume, authors, institutions, countries, journals, citation frequencies, keywords, clustering, and burst terms, and to create a visual map. Results: A total of 996 valid publications from 464 journals were included in the study. The number of publications exhibited a gradual growth trend over the years. The United States was the most productive and influential country, contributing the highest proportion of both publications and total citations. BMC Health Services Research, Toronto University, and Marshall, Bruce C. were identified as the most productive journal, institution, and author, respectively. Further analysis of keyword co-occurrence and burst detection revealed that the most prevalent keywords were “improving primary care” and “integrated care”. Conclusion: This bibliometric analysis provides a comprehensive overview of the current status and trends in NCD management over the past two decades, providing valuable insights for future research directions. It indicates a potential shift towards enhancing primary healthy care, integrated care, and digital health.

21 March 2024 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
YDYongqi Dong
Yongqi Dong
HXHongyan Xu
Hongyan Xu
ZZZhihuan Zhang
Zhihuan Zhang
ZZZhi-hang Zhou
Zhi-hang Zhou
GZGang Zhao
Gang Zhao
SXShiyong Xiao
Shiyong Xiao

24 January 2025 in International Journal of Surgery
Verified
Journal Article
Open access
YDYongqi Dong
Yongqi Dong
HXHongyan Xu
Hongyan Xu
WYWanli Yu
Wanli Yu
ZLZijing Liu
Zijing Liu
GZGang Zhao
Gang Zhao
ZLZebin Lin
Zebin Lin
Introduction: What interventions effectively prevent postoperative stenosis following endoscopic resection (ER) of superficial esophageal cancer? This study aimed to identify effective interventions or combinations through a systematic review and network meta-analysis. Methods: Six databases were systematically searched for eligible studies up to 30 April 2023, on interventions to prevent esophageal stenosis post-ER. Odds ratios (ORs) evaluated stenosis rate (primary outcome) and complications (secondary outcome), while mean differences (MD) evaluated endoscopic balloon dilatation (EBD) sessions post-stenosis. Results: Twenty-three studies involving 1271 patients and 11 different interventions were included. Eight interventions were effective in preventing post-ER stenosis: oral hydrocortisone sodium succinate and aluminum phosphate gel (OHA) (OR: 0.02, 95% credible interval [CrI]: 0.00–0.11), polyglycolic acid (PGA) + ST (OR: 0.02, 95% CrI: 0.00–0.23), oral tranilast (OT) + preemptive endoscopic balloon dilatation (PEBD) (OR: 0.08, 95% CrI: 0.01–0.77), botulinum toxin (BT) (OR: 0.10, 95% CrI: 0.03–0.32), ST (OR: 0.08, 95% CrI: 0.01–0.67), oral steroid (OS) (OR: 0.11, 95% CrI: 0.05–0.28), endoscopic triamcinolone injection (ETI) + OS (OR: 0.17, 95% CrI: 0.07–0.42), and ETI (OR: 0.18, 95% CrI: 0.11–0.30). Five interventions significantly reduced EBD sessions: PGA + ST (MD: −5.78, 95% CrI: −11.04 to −1.21), ETI + OS (MD: −3.27, 95% CrI: −5.37 to −0.72), OS (MD: −6.18, 95% CrI: −9.43 to −3.38), ETI (MD: −3.81, 95% CrI: −5.74 to −1.99), and BT (MD: −2.16, 95% CrI: −4.12 to −0.40). None of the interventions significantly increased complications. Conclusions: This study confirmed the efficacy of OS, ETI, and ETI + OS and verified five other interventions (OHA, PGA + ST, OT + PEBD, BT, and ST) in preventing stenosis. Notably, PGA + ST and BT also reduced the number of EBD sessions.

17 April 2024 in Asian Journal of Surgery
Verified
Journal Article
Open access
YDYongqi Dong
Yongqi Dong
QYQianzhang Yi
Qianzhang Yi
SXShiyong Xiao
Shiyong Xiao
SCSihao Chen
Sihao Chen